Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members

Journal of Autoimmunity

Volumn 32, Issue 1, 2009, Pages 60-63

  De Angelis, V ^a,b   Scurati, S ^a   Raschi, E ^a,b   Liutkus, A ^c   Belot, A ^c   Borghi, M O ^a,b   Meroni, P L ^a,b   Cimaz, R ^c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c Biostatistics Department   (France)

^d UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Anti beta2 glycoprotein I antibodies; Antiphospholipid syndrome; Cytokines; Toll Like Receptor

Indexed keywords

ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SCHOOL CHILD; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; CHILD; CYTOKINES; FEMALE; GENOTYPE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; PARENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SIBLINGS; THROMBOSIS; TOLL-LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58849119882     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2008.11.002     Document Type: Article

References (22)

1. Meroni P.L., Raschi E., Testoni C., Parisio A., and Borghi M.O. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev 3 (2004) 510-515
2. Hughes G.R. Hughes syndrome (the antiphospholipid syndrome): ten clinical lessons. Autoimmun Rev 7 (2008) 262-266
3. Cervera R. Lessons from the "Euro-Phospholipid" project. Autoimmun Rev 7 (2008) 262-266
4. Meroni P.L. Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity. J Autoimmun 7 (2008) 585-587
5. Meroni P.L., and Shoenfeld Y. Predictive, protective, orphan autoantibodies: the example of antiphospholipid antibodies. Autoimmun Rev 67 (2008) 438-442
6. Sestak A., and O'Neil K.M. Familial lupus and antiphospholipid syndrome. Lupus 16 (2007) 556-563
7. Forastiero R.R., Martinuzzo M.E., and de Larrañaga G.F. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus 14 (2005) 129-136
8. Bertolaccini M.L., Atsumi T., Lanchbury J.S., Caliz A.R., Katsumata K., Vaughan R.W., et al. Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost 85 (2001) 198-203
9. Pierangeli S.S., Vega-Ostertag M.E., Raschi E., Liu X., Romay-Penabad Z., De Micheli V., et al. Toll like receptor 4 is involved in antiphospholipid-mediated thrombosis: in vivo studies. Ann Rheum Dis 66 (2007) 1327-1333
10. Sorice M., Longo A., Capozzi A., Garofalo T., Misasi R., Alessandri C., et al. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 56 (2007) 2687-2697
11. Raschi E., Borghi M.O., Grossi C., Broggini V., Pierangeli S., and Meroni P.L. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus 17 (2008) 937-942
12. Tripodi A., Mancuso M.E., Chantarangkul V., Clerici M., Bader R., Meroni P.L., et al. Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants. Clin Chem 51 (2005) 1883-1885
13. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
14. Cavazzana I., Nebulosi M.N., Cetin I., Acaia B., Saino S., Borghi M.O., et al. Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?. J Autoimmun 28 (2007) 160-164
15. Raschi E., Testoni C., Bosisio D., Borghi M.O., Koike T., Mantovani A., et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101 (2003) 3495-3500
16. Satta N., Dunoyer-Geindre S., Reber G., Fish R.J., Boehlen F., Kruithof E.K., et al. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 15 (2007) 1507-1514
17. Ferwerda B., McCall M.B.B., Verheijen K., Kullberg B.J., van der Ven A.J., van der Meer J.W., et al. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14 (2008) 346-352
18. Tolusso B., Pietrapertosa D., Morelli A., De Santis M., Gremese E., Farina G., et al. IL1β and IL1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 7 (2006) 683-695
19. Chen R.H., Chwen T.C., Chen W.C., Tsai C.H., and Tsai F.J. Proinflammatory cytokine gene polymorphisms among Hashimoto's thyroiditis patients. J Clin Lab Anal 20 (2006) 260-265
20. Cvetkovic J.T., Wiklund P.G., Ahemd E., Weinehall L., Hallmans G., and Lefvert A.K. Polymorphisms of IL-1β, IL-1Ra, and TNF-a genes: a nested case-control study of their association with risk for stroke. J Stroke Cerebrovasc Dis 14 (2005) 29-35
21. Seitz M., Wirthmuller U., Moller B., and Villiger P.M. The -308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology 46 (2007) 93-96
22. Settin A., Abdel-Hady H., El-Baz R., and Saber I. Gene polymorphisms of TNF-alpha (-308), IL-10 (-1082), IL-6 (-174), and IL-1Ra (VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 28 (2007) 363-371